City talk
Apr 02, 2021
1 minute
• AstraZeneca’s CEO Pascal Soriot has accelerated the company’s development of “novel drugs” over the last seven years to fight off a takeover bid from Pfizer, says Lex in
You’re reading a preview, subscribe to read more.
Start your free 30 days